IPA chief: "Regulators are starting to turn the corner on probiotics"

This content item was originally published on www.foodnavigator-usa.com, a William Reed online publication.

By Stephen Daniells

- Last updated on GMT

Related tags European union

A new-look International Probiotics Association is creating dialogue with key regulators around the world, and the regulators are starting to turn the corner on how they regulate the friendly bugs, says the association’s executive director.

The probiotics sector continues to grow rapidly, with 20% growth reported by some sources, but regulatory issues, particularly in Europe with EFSA and the health claims regulations there, have created challenges for industry players.

Speaking with NutraIngredients-USA at the recent SupplySide West show in Las Vegas, IPA’s George Paraskevakos said that the science is key to driving market success.  

“In regards to the sector, everything seems to point towards growth; it’s healthy and we’re starting to see consolidation and acquisitions, but all of this growth is not unfounded: I think the science coming out of the sector is fueling the growth. The science and the research is unlocking the amazing potential of probiotics and the health benefits that they can bring.”

Turning his attention the regulators, Paraskevakos said that, “as a general statement, I believe regulators are starting to turn the corner when it comes to regulating probiotics. They realize that we’re not a regular mineral or vitamin ingredient or supplement, but we’re a living organism and that requires a certain expertise. I think the regulators are starting to understand that they need to look to association that has that expertise.

“We’ve looked at creating dialogue and stakeholder meetings with important regulators across different geographies. We’ve recently booked a stakeholder meeting with ANVISA in Brazil, we’re waiting for a date with the Mexican authorities, and we were at the FDA’s facility three weeks ago and they communicated that there needs to be a dialogue and they have to open up when it comes to probiotics.”

In Europe, Paraskevakos said that IPA recently opened its European office in Brussels with guests from EFSA, the European Commission, and the European Parliament. “There’s been deadlock in Europe when it comes to probiotic health claims but the message coming out of that meeting was we need to get into dialogue and maybe some pre-submission type of model,”​ he said.

Using GOED as the blueprint

The IPA has undergone through a transition period, acknowledged Paraskevakos, with the former executive director leaving in 2014.

“My goal is quite simple,”​ he said. “We are an association that brings all the stakeholders of the sector together. IPA wants to bridge these stakeholders and be the platform where they all interact and be the go-to probiotic association for all the people active in the probiotic sector.

“We’re in the process of producing guidelines and best practice documents,”​ he added. “We’re creating more media outreach. The stakeholders meetings with the government agencies will be important going forward.

“We have to have more visibility at shows and conferences. If IPA can become the GOED for the probiotic industry, then that’s the goal.”

Related news

Show more

Related products

show more

Harness the power of algae for omega-3 innovation

Harness the power of algae for omega-3 innovation

Content provided by dsm-firmenich | 22-May-2024 | Insight Guide

Algal-sourced omega-3s have limitless potential, able to scale to meet the needs of our planet’s population with twice the potency – naturally – and all...

Effera™ Human Equivalent Lactoferrin

Effera™ Human Equivalent Lactoferrin

Content provided by Helaina Inc | 17-May-2024 | Product Brochure

Helaina’s bioactive protein Effera™ is a novel branded ingredient and the first clinically studied Human Lactoferrin on the market. Human Lactoferrin is...

New postbiotic for gut & skin health benefits

New postbiotic for gut & skin health benefits

Content provided by Kerry ProActive Health | 14-May-2024 | Product Presentation

Plenibiotic™ (Lactobacillus casei subsp. casei 327) is a rice-derived postbiotic providing a holistic approach to digestive and skin health. It offers...

Related suppliers

Follow us


View more